185 related articles for article (PubMed ID: 16079316)
1. Second field tumors: a new opportunity for cancer prevention?
Braakhuis BJ; Brakenhoff RH; Leemans CR
Oncologist; 2005 Aug; 10(7):493-500. PubMed ID: 16079316
[TBL] [Abstract][Full Text] [Related]
2. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
Braakhuis BJ; Tabor MP; Kummer JA; Leemans CR; Brakenhoff RH
Cancer Res; 2003 Apr; 63(8):1727-30. PubMed ID: 12702551
[TBL] [Abstract][Full Text] [Related]
3. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis.
Braakhuis BJ; Leemans CR; Brakenhoff RH
Semin Cancer Biol; 2005 Apr; 15(2):113-20. PubMed ID: 15652456
[TBL] [Abstract][Full Text] [Related]
4. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Kummer JA; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2004 Jun; 10(11):3607-13. PubMed ID: 15173066
[TBL] [Abstract][Full Text] [Related]
5. A genetic progression model of oral cancer: current evidence and clinical implications.
Braakhuis BJ; Leemans CR; Brakenhoff RH
J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
[TBL] [Abstract][Full Text] [Related]
6. Genetic progression model for head and neck cancer: implications for field cancerization.
Califano J; van der Riet P; Westra W; Nawroz H; Clayman G; Piantadosi S; Corio R; Lee D; Greenberg B; Koch W; Sidransky D
Cancer Res; 1996 Jun; 56(11):2488-92. PubMed ID: 8653682
[TBL] [Abstract][Full Text] [Related]
7. Retinoid chemoprevention of second primary tumors.
Benner SE; Lippman SM; Hong WK
Semin Hematol; 1994 Oct; 31(4 Suppl 5):26-30. PubMed ID: 7831582
[TBL] [Abstract][Full Text] [Related]
8. Multiple head and neck tumors frequently originate from a single preneoplastic lesion.
Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Van Der Wal JE; Snow GB; Leemans CR; Braakhuis BJ
Am J Pathol; 2002 Sep; 161(3):1051-60. PubMed ID: 12213734
[TBL] [Abstract][Full Text] [Related]
9. Retinoids: application in premalignant lesions and oral cancer.
Contreras Vidaurre EG; Bagán Sebastián JV; Gavalda C; Torres Cifuentes EF
Med Oral; 2001; 6(2):114-23. PubMed ID: 11500628
[TBL] [Abstract][Full Text] [Related]
10. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications.
Bradley PJ; MacLennan K; Brakenhoff RH; Leemans CR
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):74-81. PubMed ID: 17413406
[TBL] [Abstract][Full Text] [Related]
11. Second primary tumors (SPT) of head and neck: distinguishing of "true" SPT from micrometastasis by LOH analysis of selected chromosome regions.
Giefing M; Rydzanicz M; Szukala K; Wozniak A; Wierzbicka M; Szyfter K; Kujawski M
Neoplasma; 2005; 52(5):374-80. PubMed ID: 16151577
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of head and neck cancer.
Voravud N
J Med Assoc Thai; 1996 Mar; 79(3):185-93. PubMed ID: 8708501
[TBL] [Abstract][Full Text] [Related]
14. Multiple oral squamous epithelial lesions: are they genetically related?
Jang SJ; Chiba I; Hirai A; Hong WK; Mao L
Oncogene; 2001 Apr; 20(18):2235-42. PubMed ID: 11402318
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention in head and neck cancer.
Heyne KE; Lippman SM; Hong WK
Hematol Oncol Clin North Am; 1991 Aug; 5(4):783-95. PubMed ID: 1890067
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
17. Retinoids in chemoprevention of head and neck carcinogenesis.
Lippman SM; Benner SE; Hong WK
Prev Med; 1993 Sep; 22(5):693-700. PubMed ID: 8234209
[TBL] [Abstract][Full Text] [Related]
18. Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits?
van Oijen MG; Slootweg PJ
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):249-56. PubMed ID: 10750662
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer.
Mithani SK; Taube JM; Zhou S; Smith IM; Koch WM; Westra WH; Califano JA
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4331-5. PubMed ID: 17671113
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma of the sinonasal cavity arising as a second primary in individuals with head and neck cancer.
Wolpoe ME; Goldenberg D; Koch WM
Laryngoscope; 2006 May; 116(5):696-9. PubMed ID: 16652073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
